Cialis Use
December 8th, 2008
Perhaps this was an isolated event, but most likely, Pfizer, through their multitude of sponsored researchers and physicians, is attempting to increase sales through yet another 45 means. There is currently no available research on the topic of daily prevention strategies through the use of sildenafil. Hence, this method of ‘daily prevention’ seems neither proven, nor indicated, and as such, may indeed be harmful. Novel Uses for Cialis Research in the field of erectile function and dysfunction has continued to expand rapidly. Based on the information available, some directions for future erectile dysfunction therapies can be identified (Andersson and Hedlund, 2002). The first direction is improvement of current therapeutic principles, such as with the newly introduced second generation of orally active PDE inhibitors. Another direction is the development and administration of combinations of existing therapeutic agents such as combinations of apomorphine and sildenafil. These methods seem attractive and may have a therapeutic potential in patients not responding satisfactorily to single-drug treatments in the future (Andersson and Hedlund, 2002). Since the development of Cialis, the industry has been scrambling to develop an equivalent aid for women, encouraged by significant female demand. Women have spent a minimum of $200 million for clinically proven phoney products such as Avlimil, which was earlier on touted as a natural female enhancement pill (Read, 2005). Thus far, however, the attempts to produce veritable female products have been unsuccessful while at least three are readily available for men. So why has it taken this long to develop a drug which specifically addresses women’s sexual needs? Sex therapist Judith Seifer writes that regarding sexual function, “we’re about fifteen to twenty years behind in our studies with women” compared to men (2004). Ellison writes that the FDA is under increasing pressure from congress and the public in order to clamp down on safety standards after a number of high-profile drugs, including Cialis, Vioxx and menopausal hormone therapies have been shown to cause serious side effects, which manufacturers were often aware of beforehand (Raja and Nayak, 2004).
